NASDAQ:RDNT RadNet (RDNT) Stock Price, News & Analysis $52.51 +1.89 (+3.73%) Closing price 04/2/2025 04:00 PM EasternExtended Trading$49.76 -2.76 (-5.25%) As of 04:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About RadNet Stock (NASDAQ:RDNT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RadNet alerts:Sign Up Key Stats Today's Range$48.85▼$52.5850-Day Range$45.92▼$67.9852-Week Range$45.82▼$93.65Volume847,983 shsAverage Volume633,133 shsMarket Capitalization$3.89 billionP/E RatioN/ADividend YieldN/APrice Target$73.25Consensus RatingBuy Company OverviewRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Read More… Remove Ads RadNet Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks80th Percentile Overall ScoreRDNT MarketRank™: RadNet scored higher than 80% of companies evaluated by MarketBeat, and ranked 203rd out of 927 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingRadNet has received a consensus rating of Buy. The company's average rating score is 3.40, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageRadNet has only been the subject of 4 research reports in the past 90 days.Read more about RadNet's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-5.36% Earnings GrowthEarnings for RadNet are expected to decrease by -5.36% in the coming year, from $0.56 to $0.53 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is -750.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is -750.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRadNet has a P/B Ratio of 4.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about RadNet's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.31% of the float of RadNet has been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in RadNet has recently increased by 3.00%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Sustainability and ESG4.6 / 5Environmental Score-0.52 Percentage of Shares Shorted8.31% of the float of RadNet has been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in RadNet has recently increased by 3.00%, indicating that investor sentiment is decreasing. News and Social Media2.9 / 5News Sentiment1.27 News SentimentRadNet has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for RadNet this week, compared to 6 articles on an average week.Search InterestOnly 1 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,926,730.00 in company stock.Percentage Held by InsidersOnly 5.12% of the stock of RadNet is held by insiders.Percentage Held by Institutions77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about RadNet's insider trading history. Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address RDNT Stock News HeadlinesRadNet, Inc. (NASDAQ:RDNT) COO Norman R. Hames Sells 5,000 SharesMarch 20, 2025 | insidertrades.comRadNet, Inc. (NASDAQ:RDNT) CEO Cornelis Wesdorp Sells 1,000 SharesMarch 8, 2025 | insidertrades.comTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. April 3, 2025 | Paradigm Press (Ad)A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The PackMarch 27, 2025 | msn.comRadNet (RDNT): Buy, Sell, or Hold Post Q4 Earnings?March 27, 2025 | msn.comWhat 5 Analyst Ratings Have To Say About RadNetMarch 26, 2025 | nasdaq.comBarclays Issues Pessimistic Forecast for RadNet (NASDAQ:RDNT) Stock PriceMarch 25, 2025 | americanbankingnews.comRadNet price target lowered to $60 from $74 at BarclaysMarch 25, 2025 | markets.businessinsider.comSee More Headlines RDNT Stock Analysis - Frequently Asked Questions How have RDNT shares performed this year? RadNet's stock was trading at $69.84 at the start of the year. Since then, RDNT shares have decreased by 24.8% and is now trading at $52.51. View the best growth stocks for 2025 here. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) posted its quarterly earnings results on Thursday, February, 27th. The medical research company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.21 by $0.01. The medical research company had revenue of $477.10 million for the quarter, compared to analysts' expectations of $459.42 million. RadNet had a negative net margin of 0.25% and a positive trailing twelve-month return on equity of 4.29%. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some other companies that RadNet investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Broadcom (AVGO) and Palo Alto Networks (PANW). Company Calendar Last Earnings2/27/2025Today4/03/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:RDNT CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees8,970Year Founded1980Price Target and Rating Average Stock Price Target$73.25 High Stock Price Target$88.00 Low Stock Price Target$60.00 Potential Upside/Downside+39.5%Consensus RatingBuy Rating Score (0-4)3.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E RatioN/A Forward P/E Ratio93.77 P/E GrowthN/ANet Income$3.04 million Net Margins-0.25% Pretax Margin2.05% Return on Equity4.29% Return on Assets1.45% Debt Debt-to-Equity Ratio0.89 Current Ratio2.16 Quick Ratio2.16 Sales & Book Value Annual Sales$1.83 billion Price / Sales2.12 Cash Flow$2.79 per share Price / Cash Flow18.81 Book Value$11.79 per share Price / Book4.45Miscellaneous Outstanding Shares74,042,000Free Float70,237,000Market Cap$3.89 billion OptionableOptionable Beta1.85 Social Links 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:RDNT) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.